Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

TG Therapeutics

TG Therapeutics reported $-39232000 in Net Income for its fiscal quarter ending in March of 2023.

Net Income Change
AbbVie ABBV:US USD 239M 2.23B
Alaunos Therapeutics Inc ZIOP:US USD -10048000 889K
Amgen AMGN:US USD 2.84B 1.23B
Ardelyx ARDX:US USD -26773000 37.47M
Arrowhead Research ARWR:US USD 48.68M 90M
Bayer BAYN:GR EUR 2.18B 1.57B
Biogen BIIB:US USD 387.9M 162.5M
Curis CRIS:US USD -11559000 230K
Gilead Sciences GILD:US USD 1.01B 630M
Infinity Pharmaceuticals INFI:US USD -11045000 1.82M
Intercept Pharmaceuticals ICPT:US USD -32135000 11.31M
J&J JNJ:US USD -68000000 3.59B
Karyopharm Therapeutics KPTI:US USD -34126000 4.38M
Novartis NOVN:VX USD 2.29B 827M
Novavax NVAX:US USD -293905000 111.66M
PTC Therapeutics PTCT:US USD -138959000 31.93M
Puma Biotechnology PBYI:US USD 1.4M 7.01M
Regeneron Pharmaceuticals REGN:US USD 817.8M 379.3M
Roche Holding ROG:VX CHF 3.89B 4.64B
Spectrum Pharmaceuticals SPPI:US USD -5007000 3.98M
TG Therapeutics TGTX:US USD -39232000 13.76M
Verastem VSTM:US USD -15714000 1.09M
Vertex Pharmaceuticals VRTX:US USD 699.8M 119.1M